'Sympathy goes out to anyone who lost loved ones,' says ... - dofaq.co
'Sympathy goes out to anyone who lost loved ones,' says ...
Business Today - 30 Apr 2024
The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause ...
CDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901study
Medical Dialogues - 04 May 2025
CDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901study ...
AstraZeneca scores Phase III wins for Breztri Aerosphere in asthma
FirstWord Pharma - 02 May 2025
AstraZeneca scores Phase III wins for Breztri Aerosphere in asthma ...
AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion
Fierce Pharma - 02 May 2025
AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion ...
AstraZeneca Breztri met primary endpoints in Phase III trials in asthma
Medical Dialogues - 04 May 2025
AstraZeneca Breztri met primary endpoints in Phase III trials in asthma ...
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs
The Guardian - 29 Apr 2025
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs ...
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
Business Wire - 23 Apr 2025
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology ...
How Spain Became Big Pharma’s New Hotspot in Europe
Bloomberg.com - 01 Apr 2025
How Spain Became Big Pharma’s New Hotspot in Europe ...
China, America and pay inject drama into AstraZeneca’s AGM
The Guardian - 06 Apr 2025
China, America and pay inject drama into AstraZeneca’s AGM ...
AstraZeneca
Britannica - 30 Apr 2025
AstraZeneca ...
AstraZeneca quietly exits neuroscience
BioPharma Dive - 01 May 2025
AstraZeneca quietly exits neuroscience ...
AstraZeneca's Q1 2025 Financial Results
Business Wire - 29 Apr 2025
AstraZeneca's Q1 2025 Financial Results ...
UK High Court revokes AstraZeneca’s SPC and patent for diabetes drug dapagliflozin
JUVE Patent - 30 Apr 2025
UK High Court revokes AstraZeneca’s SPC and patent for diabetes drug dapagliflozin ...
AstraZeneca says potential US tariffs manageable, faces another China fine
Reuters - 29 Apr 2025
AstraZeneca says potential US tariffs manageable, faces another China fine ...
AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drug
The Economic Times - 15 Apr 2025
AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drug ...
AstraZeneca and Qure.ai Achieve 5 Million AI-Powered Lung Cancer Screenings, Flag 50,000 High-Risk Cases Across 20 Countries
eHealth Magazine - 03 May 2025
AstraZeneca and Qure.ai Achieve 5 Million AI-Powered Lung Cancer Screenings, Flag 50,000 High-Risk Cases Across 20 Countries ...
AstraZeneca ‘committed’ to US manufacturing as profits rise
Financial Times - 29 Apr 2025
AstraZeneca ‘committed’ to US manufacturing as profits rise ...
AstraZeneca Moves Some Production To US Amid Tariff Threat
NDTV - 29 Apr 2025
AstraZeneca Moves Some Production To US Amid Tariff Threat ...
AstraZeneca says potential US tariffs manageable; faces another China fine
Business Standard - 29 Apr 2025
AstraZeneca says potential US tariffs manageable; faces another China fine ...
AstraZeneca culls a Lilly-partnered Alzheimer's drug alongside 2 other neuroscience meds in Q1 clear-out
Fierce Biotech - 29 Apr 2025
AstraZeneca culls a Lilly-partnered Alzheimer's drug alongside 2 other neuroscience meds in Q1 clear-out ...